Arkolith/Insider Trading/PTIX/Form 4

Arrow Alexander K.

Chief Financial OfficerProtagenic Therapeutics, Inc. ew (PTIX) · full profile →Form 4 · filed Oct 13, 2023
Net Buying
Open-Market Buys
$6K
Open-Market Sells
$0
Net Open-Market Flow
$6K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 12, 2023Buy(P)8K$0.81$6K46K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-037136) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML